People · Operator
Named in public records as an officer, director or promoter · active 2014–2015 · Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Inventure, LLC | — | Pharmaceuticals | Seed | $6.0M | $411K | 2015 |
| Qualegen, LLC | — | Other | Seed | $1.5M | $27.9M | 2014 |
Richard Rosene at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Rosene on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William F. Doyle | 2 | 8 |
| Richard Deslauriers | 2 | 3 |
| Jonathan Balfour | 2 | 2 |
| Robert F. Jacobs | 1 | 2 |
| Bill Doyle | 1 | 2 |
| Richard J Deslauriers | 1 | 2 |
| Kyle Salem | 1 | 2 |
| Brad J. Rummer | 1 | 1 |
| Brad F. Rummer | 1 | 1 |
| Brad Rummer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.